Citação norma APA

Hashimoto, K., Man, S., Xu, P., Cruz-Munoz, W., Tang, T., Kumar, R., & Kerbel, R. S. (2010). Potent Preclinical Impact of Metronomic Low-Dose Oral Topotecan Combined with the Antiangiogenic Drug Pazopanib for the Treatment of Ovarian Cancer.

Citação norma Chicago

Hashimoto, Kae, Shan Man, Ping Xu, William Cruz-Munoz, Terence Tang, Rakesh Kumar, and Robert S. Kerbel. Potent Preclinical Impact of Metronomic Low-Dose Oral Topotecan Combined With the Antiangiogenic Drug Pazopanib for the Treatment of Ovarian Cancer. 2010.

Citação norma MLA

Hashimoto, Kae, et al. Potent Preclinical Impact of Metronomic Low-Dose Oral Topotecan Combined With the Antiangiogenic Drug Pazopanib for the Treatment of Ovarian Cancer. 2010.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.